Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.35
-4.15 (-8.38%)
Nov 17, 2026, 1:30 PM CST

Pell Bio-Med Technology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,608306.7427.37167.68172.4115.78
Short-Term Investments
416.43351479.75938.15536-
Trading Asset Securities
24.84-29.06---
Cash & Short-Term Investments
2,049657.7936.181,106708.4115.78
Cash Growth
184.50%-29.75%-15.34%56.10%511.84%-
Accounts Receivable
6.545.073.757.616.054.5
Other Receivables
5.73.212.40.330.366.12
Receivables
12.248.276.157.946.4110.62
Inventory
68.496.626.183.764.584.24
Prepaid Expenses
34.455.469.228.865.841.1
Other Current Assets
0.28653.372000.650.160.08
Total Current Assets
2,1641,3311,1581,127725.39131.82
Property, Plant & Equipment
735.92709.81386.45260.92298.97249.74
Long-Term Investments
64.050.270.370.370.260.26
Other Intangible Assets
23.42.931.892.42.711.47
Other Long-Term Assets
71.1667.8198.3927.4417.0710.61
Total Assets
3,0592,1121,7451,4181,044393.89

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
21.355.834.496.995.728.61
Accrued Expenses
-106.4964.1239.7414.5819.19
Short-Term Debt
100100200-5-
Current Portion of Leases
30.9627.9927.5525.0925.0710.76
Current Unearned Revenue
-0.020.02--0.75
Other Current Liabilities
87.3368.6425.1717.476.864.87
Total Current Liabilities
239.64308.97321.3589.357.2444.18
Long-Term Leases
94.48109.28137.27147.47172.56124.84
Other Long-Term Liabilities
0.020.02----
Total Liabilities
334.15418.27458.62236.77229.79169.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
655.8587.98578.43539.43443.65333.76
Additional Paid-In Capital
3,7181,9101,8041,449774.2577.38
Retained Earnings
-1,888-1,631-1,207-817.85-419.09-188.96
Treasury Stock
-0.6-0.8-0.8-0.8--
Comprehensive Income & Other
1.04555.745.52-2.132.69
Total Common Equity
2,4871,4221,1801,170800.94224.86
Minority Interest
238.36272.07106.2911.1813.670.01
Shareholders' Equity
2,7251,6941,2861,181814.6224.87
Total Liabilities & Equity
3,0592,1121,7451,4181,044393.89

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
225.44237.27364.82172.56202.63135.6
Net Cash (Debt)
1,824420.43571.36933.27505.77-19.82
Net Cash Growth
283.08%-26.41%-38.78%84.52%--
Net Cash Per Share
1.460.360.501.010.64-0.03
Filing Date Shares Outstanding
1,2981,1741,1561,078887.3665.54
Total Common Shares Outstanding
1,2981,1741,1561,078887.3665.54
Working Capital
1,9251,022836.381,038668.1587.64
Book Value Per Share
1.921.211.021.090.900.34
Tangible Book Value
2,4631,4191,1781,168798.22223.39
Tangible Book Value Per Share
1.901.211.021.080.900.34
Machinery
-310.3395.0590.3781.8475.31
Construction In Progress
-285.99148.34---
Leasehold Improvements
-104.1286.7286.7286.1886